Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent

Author(s): Santosh N. Mokale*, Nikhil S. Sakle, Swati A. Bhavale, Deepak K. Lokwani, Vishakha R. Shelke.

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 18 , Issue 7 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Methods: A novel series of isoxazole (S21-S30) derivatives were designed, synthesized and screened for their anticancer activity against estrogen receptor-positive MCF-7 and negative MDA-MB-435 breast cancer cell lines. The synthesized derivative has the ability to inhibit the growth of the human breast cancer cell line at low concentrations. In vivo anticancer activity was performed on virgin female sprague dawley rats.

Results: The result shows that compound S23 has more selectivity and marked estrogen modulator activity than the standard tamoxifen.

Keywords: Chalcone, isoxazole, breast cancer, estrogen receptor, S21-S30, tamoxifen.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 18
ISSUE: 7
Year: 2018
Page: [1009 - 1015]
Pages: 7
DOI: 10.2174/1871520618666171129153655
Price: $58

Article Metrics

PDF: 18
HTML: 10